Cosmederm Bioscience Introduces Steve Massah As New Chief Operating Officer

Cosmederm Bioscience, a leading specialty pharmaceutical company focused on dermatology and pain management, has hired Steve Massah as the company's new Chief Operating Officer. As COO, Massah will provide strategic and tactical leadership, and management of manufacturing, product development, quality and product shipment and logistics. His work will ensure compliance with all government regulations and industry guidelines for the company's portfolio of topical therapeutic products in the OTC, cosmeceutical skincare and prescription markets.

Suggested Articles

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.

After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech.